Yakult Pharmaceutical Industry

Yakult Pharmaceutical Industry Co., Ltd. is the specialized pharmaceutical subsidiary of Yakult Honsha, primarily focused on the oncology therapeutic area. The company gained international recognition for the development of irinotecan hydrochloride (Campto), a pivotal chemotherapy agent used in the treatment of various solid tumors, particularly colorectal cancer. Beyond its oncology portfolio, Yakult Pharmaceutical is a major manufacturer of active pharmaceutical ingredients (APIs), enzymes, and specialized reagents for the healthcare and food industries. The company operates high-standard manufacturing facilities in Japan that comply with global GMP standards. Through strategic collaborations with global pharmaceutical firms, Yakult ensures the distribution and clinical application of its products worldwide. Its business model integrates drug discovery, manufacturing, and the supply of essential biochemical components.